Mesothelioma and Asbestos

British scientists are developing as well as studying a recent genetic test to improve the odds for cancer patients as well as lower the side effects of chemotherapy. The genetic test looks at DNA that is extracted from a tiny blood sample to predict how patients will respond to chemotherapy drugs. The results of the test can help doctors to lower doses as well as lower side effects for some patients, or to help treat other patients more aggressively. Incase the current trial is a success, the recent genetic test could be used in as little as five years.

Chemotherapy works by using powerful drugs to kill cancer cells or halt them from dividing as well as spreading, but it as well as damages wholesome cells as well as creates unpleasant side effects. Further complicating the matter, each cancer patient reacts differently to various cancer drugs, which makes it difficult for doctors to figure out the correct dosage. Side effects can range from hair loss, nausea as well as upset stomach to kidney damage as well as permanent nerve damage.

The recent genetic test is designed to look at how individual patients respond to certain platinum-based cancer drugs. Patients currently receive standardized treatments where the effect on individual patients is unknown at the start, but the test should make chemotherapy outcomes more predictable. This would improve patients’ chances as well as as well as save money.

For the filled story, go to Mail Online.